loading

Trevi Therapeutics Inc Stock (TRVI) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
33.28%
11.91
8.933 9.045 8.382 7.563
Interest Income/Expense
75.00%
0.001
0.004 0.003 0.153 0.231
Operating Income/Loss
33.28%
-11.91
-8.933 -9.045 -8.382 -7.563
Nonoperating Income/Loss
11.86%
0.996
1.13 1.334 1.207 1.155
Income/Loss From Continuing Operations Before Tax
39.82%
-10.91
-7.803 -7.711 -7.175 -6.408
Income Tax Expense/Benefit
144.44%
-0.008
0.018 -0.013 -0.03 -0.007
Income/Loss From Continuing Operations After Tax
39.39%
-10.90
-7.821 -7.698 -7.145 -6.401
Net Income/Loss
39.39%
-10.90
-7.821 -7.698 -7.145 -6.401
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
65,161%
99.52
0.1525 99.33 98.70 98.61
Diluted Average Shares
65,161%
99.52
0.1525 99.33 98.70 98.61
Basic Earnings Per Share
37.50%
-0.11
-0.08 -0.08 -0.07 -0.06
Diluted Earnings Per Share
37.50%
-0.11
-0.08 -0.08 -0.07 -0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):